When we started having discussions with CanSino, they were with NRC, the National Research Council, and CanSino. Our interactions were with the company, which was in the business of undertaking clinical trials to show the safety and effectiveness of the vaccine. The interaction between that company and the government was not really an issue that I was looking at.
On March 11th, 2021. See this statement in context.